Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 300
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT07279454 | The EAT-FIBRE Study. | ||
| NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | ||
| NCT04523116 | Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 | ||
| NCT04868227 | Scottish Vitamin D Intervention Study | ||
| NCT03720041 | Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT03096093 | Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer | ||
| NCT05848765 | Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy | ||
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer | ||
| NCT03288532 | Renal Adjuvant MultiPle Arm Randomised Trial | ||
| NCT06714630 | The PROSECCA Study, Answering New Questions in Prostate Cancer | ||
| NCT02024009 | Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | ||
| NCT04648033 | Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC | ||
| NCT02071940 | PLX3397 KIT in Acral aNd mucOsal Melanoma | ||
| NCT02741856 | Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation | ||
| NCT00005056 | Bryostatin 1 In Treating Patients With Progressive Kidney Cancer | ||
| NCT00134108 | Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients | ||
| NCT05047107 | Biology and Genetics of Smouldering Myeloma | ||
| NCT01585701 | Phase I Study of AT13148, a Novel AGC Kinase Inhibitor | ||
| NCT05038657 | Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). | ||
| NCT01650428 | Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | ||
| NCT00058032 | CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women | ||
| NCT06320067 | A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer | ||
| NCT01324115 | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors | ||
| NCT04908111 | A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 | ||
| NCT02403102 | Imageguided Theranostics in Multiple Myeloma | ||
| NCT01902667 | Preoperative Imaging in Retroperitoneal Sarcoma | ||
| NCT03916510 | Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer | ||
| NCT05368298 | SCOOT: Sample Collection for DART | ||
| NCT00006476 | Suramin in Treating Patients With Recurrent Bladder Cancer | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | ||
| NCT02272478 | Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations | ||
| NCT07172958 | Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) | ||
| NCT04870580 | [18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy | ||
| NCT03150576 | Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer | ||
| NCT05770544 | DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. | ||
| NCT02121639 | Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy | ||
| NCT01266486 | Effect of Metformin on Breast Cancer Metabolism | ||
| NCT05097625 | Head and Neck Early Relapse Detection Study (HERD) | ||
| NCT00989105 | Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | ||
| NCT01862003 | Phase I/II Trial of Antagonism of HER in GI Cancer | ||
| NCT00977210 | Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors | ||
| NCT02310997 | Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) | ||
| NCT01937533 | Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer | ||
| NCT03004755 | The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study | ||
| NCT00757965 | Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom | ||
| NCT01926236 | Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers | ||
| NCT00554775 | WBRT & Erlotinib in Advanced NSCLC and Brain Metastases | ||
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer |
